Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Boehringer Ingelheim
Covington
Mallinckrodt
Moodys
Medtronic
Queensland Health
McKesson
Deloitte
QuintilesIMS

Generated: February 23, 2018

DrugPatentWatch Database Preview

PROBUPHINE Drug Profile

« Back to Dashboard

When do Probuphine patents expire, and what generic alternatives are available?

Probuphine is a drug marketed by Braeburn Pharms Inc and is included in one NDA. There is one patent protecting this drug.

This drug has ten patent family members in seven countries.

The generic ingredient in PROBUPHINE is buprenorphine hydrochloride. There are twenty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride profile page.
Summary for PROBUPHINE
Drug patent expirations by year for PROBUPHINE
Pharmacology for PROBUPHINE

US Patents and Regulatory Information for PROBUPHINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Braeburn Pharms Inc PROBUPHINE buprenorphine hydrochloride IMPLANT;IMPLANTATION 204442-001 May 26, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Braeburn Pharms Inc PROBUPHINE buprenorphine hydrochloride IMPLANT;IMPLANTATION 204442-001 May 26, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for PROBUPHINE

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Julphar
Colorcon
Fish and Richardson
McKesson
Healthtrust
Chinese Patent Office
Argus Health
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot